The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Recipharm Buys 10% Of Takeover Target Consort Medical

Wed, 22nd Jan 2020 14:31

(Alliance News) - Sweden's Recipharm AB on Wednesday said it acquired roughly 10% of shares in London-listed medical devices maker Consort Medical PLC, the object of an agreed GBP505 million takeover offer.

Recipharm on Wednesday purchased 9.9% of Consort's stock, just shy of 4.9 million shares, at 1,010 pence each, about GBP49.3 million in total.

The 1,010p price is in line with Recipharm's valuation of Consort shares in November, when the takeover was agreed.

In a second transaction, it purchased 118,563 Consort shares, a 0.2% stake, at 1,000p, GBP1.2 million in total.

Consort shares were flat at 1,010.00p each in London on Wednesday afternoon.

Under the agreed GBP505 million takeover offer, Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort.

Though Recipharm in November said it may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort said.

Recipharm on Wednesday said its offer remains open to acceptances until Thursday afternoon.

Last Tuesday, the company said German regulators approved the takeover, though the offer still needs the consent from competition regulators in Ireland.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2015 06:15

UK Dividends Calendar - Week Ahead

Read more
6 Feb 2015 16:01

UK Dividends Calendar - Week Ahead

Read more
4 Feb 2015 14:35

Sector movers: GSK leads defensive pharma stocks higher

A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of

Read more
4 Feb 2015 08:23

Consort Medical Signs Multi-Year Supply Agreement

Read more
29 Jan 2015 10:53

Consort Medical Invests Further GBP2.2 Million In Atlas Genetics

Read more
15 Jan 2015 06:21

UK Dividends Calendar - Week Ahead

Read more
14 Jan 2015 16:04

UK Dividends Calendar - Week Ahead

Read more
14 Jan 2015 06:15

UK Dividends Calendar - Week Ahead

Read more
13 Jan 2015 16:01

UK Dividends Calendar - Week Ahead

Read more
13 Jan 2015 06:24

UK Dividends Calendar - Week Ahead

Read more
12 Jan 2015 16:24

UK Dividends Calendar - Week Ahead

Read more
12 Jan 2015 06:18

UK Dividends Calendar - Week Ahead

Read more
9 Jan 2015 16:09

UK Dividends Calendar - Week Ahead

Read more
9 Jan 2015 06:20

UK Dividends Calendar - Week Ahead

Read more
4 Dec 2014 08:46

Thursday broker round-up

Aberdeen: Charles Stanley downgrades to 'hold'. Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation. Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation. Belgravium Technologies: WH Irelan

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.